CliniSys Hires Mark Spencer as Senior Vice President of Global Strategy

CliniSys GroupCliniSys announced that Mark Spencer has joined the company as Senior Vice President of Global Strategy. A 25-year veteran in the life sciences and healthcare IT industry, Mark will be charged with driving growth globally.

As the world looks to improve public health now and after the pandemic, Mark will work closely with the senior leadership team to realise CliniSys' vision to support its customers both inside and beyond the walls of the clinical laboratory to embrace a new wave of community laboratories and digital diagnostics in healthcare, toxicology, agriculture, water and environmental testing.

The appointment follows CliniSys' recent acquisition of HORIZON Lab Systems and merger with Sunquest Information Systems. Mark will play a critical role in integrating these business lines and product offerings to help organisations and governments globally better fight disease.

"CliniSys is at an exciting stage of growth after its recent M&A activity, priming it to deliver the integrated and holistic laboratory diagnostics that will drive the next wave of innovation in disease surveillance and tracking," said Mark Spencer. "That is why I am looking forward to returning to the company and driving the strategies that will accelerate our growth in key regions globally."

A former manager at Sunquest, Mark rejoins from Abbott Informatics, where he led the successful growth of its former laboratory information management system (STARLIMS). Mark began his career in the military, serving six years as a management engineer in the United States Air Force.

"Mark brings with him a deep knowledge of healthcare and technology, and a wealth of experience leading an impressive list of successful business transformations in the sector," said CliniSys CEO Michael Simpson. "We are delighted to have him on board for this next stage in our growth."

About CliniSys

CliniSys, headquartered in Chertsey, England and Tucson, Arizona, is one of the largest provider of laboratory information systems, order entry and result consultation, and public health solutions in disease surveillance and outbreak management across the United Kingdom, Europe, and the United States. For 40 years, successfully specialising in complex and the wide scale delivery of comprehensive laboratory and public health solutions in over 3,000 laboratories across 34 countries using CliniSys solutions.

Our combined cross-discipline expertise provides customers with solutions to support laboratory workflow across clinical, histology, molecular, genetics, including order management, reporting and results delivery. Additionally, we serve laboratories in environmental testing, water quality, agriculture, and toxicology.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...